Cyberspace Chat: Safe Management of Patients on Plavix (Clopidogrel) for Hair Restoration Surgery

This document discusses the management of patients on the anti-platelet medication Plavix (clopidogrel) for hair restoration surgery (HRS). The consensus among doctors in the discussion is that HRS doctors should work with the prescribing primary care physician, cardiologist, or surgeon to determine if it is safe to temporarily discontinue Plavix prior to surgery. It is important to accurately assess the risk and benefit of discontinuing the medication. Plavix works by inhibiting platelet aggregation, and its effects last for approximately 7-10 days. The manufacturers recommend discontinuing Plavix for at least 5 days prior to surgery to prevent bleeding complications. Restarting the medication after surgery should be done based on clinical judgment and input from the prescribing physician. Medical clearance for elective cosmetic surgery is also recommended for patients with serious medical conditions.